skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Early diagnosis and regional evaluation of radiation mucositis by newly developed TC-99M DTPA labelled agent

Journal Article · · Journal of Nuclear Medicine
OSTI ID:198031
; ;  [1]
  1. Kanazawa Medical Univ., Ishikawa (Japan); and others

We have developed a new drug for treating acute radiation mucositis which consists of a steroid with potent localized anti-inflammatory effect, and sodium alginate with strong adherence to mucosal surface, and since then we have treated many patients with success. In the present study, we labelled this agent with Tc-99m DTPA, and administered to 10 healthy volunteers and 35 patients with acute radiation mucositis, and determined the values of mean transit time (MTT) and T1/2 from the dynamic phase and the time taken for the mixture to reach to cardia according to Talliefer`s method. Abnormal radionuclide (RN) accumulation in the esophagus was evaluated at 10 minutes after the administration and, the ratio of abnormal RN accumulation count were calculated. In the healthy volunteers, the MTT was 2.67 seconds, T1/2 14.0 seconds, and the time for the drug to reach the stomach 5.25 seconds. Even in the patients with acute radiation mucositis, these values were not significantly different from the healthy controls. However, the images taken at 10 minutes after the administration revealed abnormal RN accumulation corresponding to the irradiated region in all patients. The ratio of this abnormal RN accumulation to the total RN count in the esophagus was 52.48%, the pre-administration RN ratio was 6.45%. None of the healthy volunteers produced abnormal RN accumulation. The ratio of total RN count in the esophagus to pre-administration RN count was only 1.87% in the healthy volunteers, whereas 11.39% in the radiation mucositis group. When Tc-99m DTPA-labelled water was used similarly, the region of radiation esophagitis was not identified on scintigraphy. It was thus suggested that diagnosis of radiation mucositis could be made only with this new agent of high viscosity and very strong mucous adhesive property. Owing to its repeatability and simplicity, this new agent seemed to be useful to make the early diagnosis and regional evaluation of radiation mucositis possible.

OSTI ID:
198031
Report Number(s):
CONF-940605-; ISSN 0161-5505; TRN: 95:007029-0173
Journal Information:
Journal of Nuclear Medicine, Vol. 35, Issue Suppl.5; Conference: 41. annual meeting of the Society of Nuclear Medicine, Orlando, FL (United States), 5-8 Jun 1994; Other Information: PBD: May 1994
Country of Publication:
United States
Language:
English